Search for: "In Re Silicone Gel Breast Implant" Results 41 - 60 of 62
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 May 2013, 5:59 am by Schachtman
The silicone gel-breast implant litigation provides an interesting case study of the phenomenon. [read post]
14 Jan 2010, 5:23 am by Sean Wajert
Co., 888 F.2d 45 (6th Cir. 1989) (applying Michigan law); In Re: Silicone Gel Breast Implants Products, 996 F. [read post]
22 Feb 2012, 6:53 pm by Schachtman
The discussion of common-benefit funds could benefit from discussing some of the mechanics of ensuring that monies in the funds are returned to claimants at the conclusion of the litigation to avoid improprieties, such as have been seen in MDL 926, In re Silicone Gel Breast Implants Litigation. [read post]
4 Mar 2012, 9:02 am by Schachtman
  Despite having case law cited to it (such as In re Ephedra), the trial court looked to the Reference Manual on Scientific Evidence, a resource that seems to be ignored by many federal judges, and rejected the bogus argument. [read post]
5 Jun 2013, 5:29 am by Schachtman
Supp. 1151, 1160 (E.D.La. 1997) (noting, in penile implant case, that “any” increased risk suggests that the exposure “may” have played some causal role) In re Breast Implant Litigation, 11 F. [read post]
18 Mar 2011, 10:04 am by Schachtman
August 16, 2001) (excluding causation opinion testimony given contrary epidemiologic studies; noting that sufficient epidemiologic evidence requires relative risk greater than two) In re Silicone Gel Breast Implant Litig., 318 F. [read post]
2 May 2013, 9:23 am by Schachtman
  In the silicone-gel breast implant litigation, the plaintiffs’ steering committee submitted banker boxes of studies and argument to the court’s appointed expert witnesses, in an attempt to manufacture causation. [read post]
14 Aug 2011, 9:11 am by Schachtman
  In the silicone gel breast implant litigation, for instance, plaintiffs relied upon a collection of studies that looked very plausible from their peer-reviewed publications. [read post]
12 Dec 2021, 2:22 pm by admin
Supp. 2d 992, 1199–1200 (E.D.N.Y. 2006), rev’d on other grounds, 522 F.3d 215 (2d Cir. 2008) (describing confounding in studies of low-tar cigarettes, where authors failed to account for confounding and assessing healthier life styles in users) Third Circuit In re Zoloft Prods. [read post]
23 Feb 2020, 9:54 am by Schachtman
Nor does Smith delve into how Swan sought to reprise her performance in the silicone gel breast implant litigation, only to be booted by several judges as an expert witness. [read post]
4 May 2013, 3:17 pm by Schachtman
  Robbins is a member of SKAPP, the organization started with plaintiffs’ counsel’s slush fund money diverted from MDL 926, the silicone-gel breast implant litigation. [read post]
19 Mar 2022, 2:09 pm by admin
Risk assessments would seemingly be about assessing risks, but they are not. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
10 Feb 2023, 4:44 am by admin
Putting aside the idiosyncratic chapter by the late Professor Berger, most of the third edition of the Reference Manual presented guidance on many important issues. [read post]
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
12 Jun 2023, 1:09 pm by admin
In scientific publishing, when scientists make a mistake, they publish an erratum or a corrigendum. [read post]